Doctor of Science Dagmar Garcia Rivera, director of research at the Finlay Institute of Vaccines (IFV), announced the beginning Monday of the second stage of the intervention study of Soberana 02, an anti-COVID-19 vaccine candidate developed by that institution of the BioCubaFarma business group.

Cuban foreign minister, Bruno Rodriguez Parrilla, highlighted today the role of biotechnology in the country, which guarantees health and saves lives despite the permanent choking of the economic, commercial and financial blockade of the United States.